(Q36511924)

14 August 2017

In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis (English)

1 reference

14 August 2017

0 references

0 references

Shah PL

1

1 reference

14 August 2017

Scott SF

2

1 reference

14 August 2017

Knight RA

3

1 reference

14 August 2017

Marriott C

4

1 reference

14 August 2017

Ranasinha C

5

1 reference

14 August 2017

Hodson ME

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

14 August 2017

1 reference

14 August 2017

51

1 reference

14 August 2017

119-125

1 reference

14 August 2017

2

1 reference

A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Drug effects on viscoelasticity of mucus.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Changes in the normal maximal expiratory flow-volume curve with growth and aging

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Actin is the naturally occurring inhibitor of deoxyribonuclease I

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Cystic fibrosis in adolescents and adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Cystic fibrosis: respiratory problems and their treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Effect of nondialyzable solids concentration and viscoelasticity on ciliary transport of tracheal mucus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Depolymerization of F-actin by deoxyribonuclease I

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Clearance of mucus by simulated cough.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

The role of mucus viscoelasticity in cough clearance.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

Physical properties of sputum. VII. Rheologic properties and mucociliary transport

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473012

On the transport of mucus and its rheologic simulants in ciliated systems

21 September 2018

1 reference

12 December 2020

Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis

1 reference

12 December 2020

A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis

1 reference

12 December 2020

The clinical effect and the effect on the ciliary motility of oral N-acetylcysteine in patients with cystic fibrosis and primary ciliary dyskinesia

1 reference

12 December 2020

N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility

1 reference

12 December 2020

The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum

1 reference

12 December 2020

A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis

1 reference

12 December 2020

Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study

1 reference

12 December 2020

The changing epidemiology of cystic fibrosis

1 reference

12 December 2020

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis

1 reference

12 December 2020

Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis

1 reference

12 December 2020

Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.51.2.119

1 reference

14 August 2017

1 reference

14 August 2017

1 reference